EcoDrugPlus

Cathepsin S

Ensembl ID : ENSCLAG00000012118
Gene Symbol: CTSS
2 Cross references
270 Possible Orthologues:

Cell Division Cycle 7

Ensembl ID : ENSCLAG00000007469
Gene Symbol: CDC7
2 Cross references
209 Possible Orthologues:

Checkpoint Kinase 1

Ensembl ID : ENSCLAG00000014393
Gene Symbol: CHEK1
1 Cross references
178 Possible Orthologues:

Checkpoint Kinase 2

Ensembl ID : ENSCLAG00000013905
Gene Symbol: CHEK2
2 Cross references
206 Possible Orthologues:

Cholecystokinin A Receptor

Ensembl ID : ENSCLAG00000001729
Gene Symbol: CCKAR
3 Cross references
201 Possible Orthologues:

Cholecystokinin B Receptor

Ensembl ID : ENSCLAG00000016095
Gene Symbol: CCKBR
2 Cross references
270 Possible Orthologues:

Cholinergic Receptor Muscarinic 1

Ensembl ID : ENSCLAG00000000446
Gene Symbol: CHRM1
3 Cross references
104 Possible Orthologues:

Cholinergic Receptor Muscarinic 2

Ensembl ID : ENSCLAG00000017448
Gene Symbol: CHRM2
2 Cross references
261 Possible Orthologues:

Cholinergic Receptor Muscarinic 3

Ensembl ID : ENSCLAG00000017786
Gene Symbol: CHRM3
2 Cross references
257 Possible Orthologues:

Cholinergic Receptor Muscarinic 4

Ensembl ID : ENSCLAG00000013251
Gene Symbol: CHRM4
3 Cross references
186 Possible Orthologues:

Cholinergic Receptor Muscarinic 5

Ensembl ID : ENSCLAG00000017868
Gene Symbol: CHRM5
3 Cross references
264 Possible Orthologues:

Cholinergic Receptor Nicotinic Alpha 3 Subunit

Ensembl ID : ENSCLAG00000008969
Gene Symbol: CHRNA3
2 Cross references
202 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).